clenbuterol has been researched along with primidone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Burniston, JG; Chester, N; Clark, WA; Goldspink, DF; Tan, LB | 1 |
2 other study(ies) available for clenbuterol and primidone
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Dose-dependent apoptotic and necrotic myocyte death induced by the beta2-adrenergic receptor agonist, clenbuterol.
Topics: Adrenergic beta-Agonists; Animals; Apoptosis; Caspase 3; Caspases; Cell Count; Clenbuterol; Dose-Response Relationship, Drug; Immunohistochemistry; Male; Muscle Cells; Necrosis; Primidone; Rats; Rats, Wistar; Time Factors | 2005 |